Atypical Adenomatous Hyperplasia of the Lung: A Probable Forerunner in the Development of Adenocarcinoma of the Lung

[1]  S. Rodenhuis,et al.  K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. , 1990, The New England journal of medicine.

[2]  V. Roggli,et al.  Prevalence of pulmonary atypical alveolar cell hyperplasia in an autopsy population: a study of 100 cases. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[3]  P. Pratt,et al.  Pathology of the Lung, 3rd, H. Spencer. Pergamon Press, Oxford, U.K. (1977), 1100, illustrated. US$95.00. (2 volumes). , 1978 .

[4]  S. Hecht,et al.  Retroviral aetiopathogenesis of ovine pulmonary carcinoma: a critical appraisal. , 1996, The British veterinary journal.

[5]  N. Müller,et al.  Glandular neoplasia of the lung. A proposed analogy to colonic tumors , 1988, Cancer.

[6]  T. Nobel,et al.  Bronchiolo-alveolar cell carcinoma. Animal model: pulmonary adenomatosis of sheep, pulmonary carcinoma of sheep, pulmonary carcinoma of sheep (Jaagsiekte). , 1978, The American journal of pathology.

[7]  R. Skjærven,et al.  Mean nuclear area and histological grade of axillary-node tumour in breast cancer, related to prognosis , 1982, British Journal of Cancer.

[8]  H. Spencer,et al.  Lung scar cancers. , 1957, The British journal of tuberculosis and diseases of the chest.

[9]  J. Crocker,et al.  Study of nuclear sizes in the centres of malignant and benign lymphoid follicles. , 1983, Journal of clinical pathology.

[10]  I. Wistuba,et al.  Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas. , 1997, Cancer research.

[11]  Roberta R. Miller.  Bronchioloalveolar Cell Adenomas , 1990, The American journal of surgical pathology.

[12]  Tumor cell heterogeneity and subpopulations with metastatic ability in differentiated adenocarcinoma of the lung. Histologic and cytofluorometric DNA analyses. , 1991, Chest.

[13]  R. Hruban,et al.  p53 alterations in atypical alveolar hyperplasia of the human lung. , 1998, Human pathology.

[14]  P. Nowell.  Cancer, chromosomes, and genes. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[15]  Feng Li,et al.  Mass screening for lung cancer with mobile spiral computed tomography scanner , 1998, The Lancet.

[16]  M. Lairmore,et al.  The etiology and pathogenesis of ovine pulmonary carcinoma (sheep pulmonary adenomatosis). , 1988, Veterinary microbiology.

[17]  Takaaki Ito,et al.  Expression of cyclin D1, retinoblastoma gene protein, and p16 MTS1 protein in atypical adenomatous hyperplasia and adenocarcinoma of the lung , 1998, Virchows Archiv.

[18]  W. Travis,et al.  United States lung carcinoma incidence trends: Declining for most histologic types among males, increasing among females , 1996, Cancer.

[19]  M. Barbacid,et al.  Oncogenes in solid human tumours , 1982, Nature.

[20]  T. Sekiya,et al.  Aberrations of the p53 tumor suppressor gene in human non-small cell carcinomas of the lung. , 1992, Cancer research.

[21]  V. Gouyer,et al.  Immunohistochemical study of p53 in human lung carcinomas. , 1993, The American journal of pathology.

[22]  F. Tezuka,et al.  Comparative ultrastructural study of atypical adenomatous hyperplasia and adenocarcinoma of the human lung. , 1998, Ultrastructural pathology.

[23]  J. Crocker,et al.  Study of nuclear diameters in non-Hodgkin's lymphomas , 1982, Journal of clinical pathology.

[24]  S. Goodman,et al.  Overexpression of the p53 Tumor Suppressor Gene Product in Primary Lung Adenocarcinomas Is Associated with Cigarette Smoking , 1993, The American journal of surgical pathology.

[25]  J. Ritter.  Pulmonary atypical adenomatous hyperplasia. A histologic lesion in search of usable criteria and clinical significance. , 1999, American journal of clinical pathology.

[26]  O. Auerbach,et al.  Development of carcinoma of the lung as reflected in exfoliated cells , 1974, Cancer.

[27]  J. Minna,et al.  Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation. , 1992, Oncogene.

[28]  A. Cuba-Caparó,et al.  Pulmonary adenomatosis of sheep--metastasizing bronchiolar tumors. , 1961, American journal of veterinary research.

[29]  Y. Inayama,et al.  Proliferative potential and p53 overexpression in precursor and early stage lesions of bronchioloalveolar lung carcinoma. , 1995, The American journal of pathology.

[30]  R. Miller.  Alveolar atypical hyperplasia in association with primary pulmonary adenocarcinoma: a clinicopathological study of 10 cases. , 1993, Thorax.

[31]  Y. Shimosato,et al.  Histological Typing of Lung and Pleural Tumours , 1999, World Health Organization.

[32]  K. Haley,et al.  Calcitonin driven v-Ha-ras induces multilineage pulmonary epithelial hyperplasias and neoplasms , 1999, Oncogene.

[33]  P. Cagle,et al.  Potential utility of p53 immunopositivity in differentiation of adenocarcinomas from reactive epithelial atypias of the lung. , 1996, Human pathology.

[34]  O. Auerbach,et al.  Carcinoma-in-situ and early invasive carcinoma occurring in the tracheobronchial trees in cases of bronchial carcinoma. , 1957, The Journal of thoracic surgery.

[35]  T. Nakajima,et al.  Cytofluorometric analysis of metastases from lung adenocarcinoma with special reference to the difference between hematogenous and lymphatic metastases , 1991, Cancer.

[36]  Frank McCormick,et al.  ras GTPase activating protein: Signal transmitter and signal terminator , 1989, Cell.

[37]  W. Travis,et al.  Histological Classification of Lung and Pleural Tumours , 1999 .

[38]  M. Boon,et al.  Morphometric grading of bladder tumors in comparison with histologic grading by pathologists. , 1983, Human pathology.

[39]  W. Rom,et al.  Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma. , 1995, Cancer research.

[40]  M. Noguchi,et al.  Adenocarcinoma of the lung: its development and malignant progression , 1993 .

[41]  K. Sugimachi,et al.  Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma. , 1991, European journal of cancer.

[42]  U. Pastorino,et al.  Deletions of 17p and p53 mutations in preneoplastic lesions of the lung. , 1992, Cancer research.

[43]  林宏行.  Analysis of p21 Wafl/Cipl Expression in Normal,Premalignant,and Malignant Cells during the Development of Human Lung Adenocarcinoma(ヒト肺腺癌の発生過程における前癌病変細胞,及び癌細胞のp21蛋白発現の解析) , 1997 .

[44]  M. Mason,et al.  Carcinoma in situ and early invasive carcinoma of the bronchus , 1969, Thorax.

[45]  L. Montuenga,et al.  Expression of peptidyl-glycine alpha-amidating mono-oxygenase (PAM) enzymes in morphological abnormalities adjacent to pulmonary tumors. , 1996, The American journal of pathology.

[46]  A. Gown,et al.  Widespread p53 overexpression in human malignant tumors. An immunohistochemical study using methacarn-fixed, embedded tissue. , 1992, The American journal of pathology.

[47]  Y. Satoh,et al.  Multiple atypical adenomatous hyperplasia of type II pneumonocytes and bronchiolo‐alveolar carcinoma , 1990, Histopathology.

[48]  横崎 典哉.  Differentiation of atypical adenomatous hyperplasia and adenocarcinoma of the lung by use of DNA ploidy and morphometric analysis , 1997 .

[49]  S. Enchev.  ON THE QUESTION OF MALIGNANT FORMS OF THE SO-CALLED PULMONARY ADENOMATOSIS (JAAGSIEKTE) IN SHEEP. , 1963, Neoplasma.

[50]  P. Hand,et al.  ras gene alterations and enhanced levels of ras p21 expression in a spectrum of benign and malignant human mammary tissues. , 1986, Laboratory investigation; a journal of technical methods and pathology.

[51]  Takaaki Ito,et al.  Cytodifferentiation of atypical adenomatous hyperplasia and bronchioloalveolar lung carcinoma: immunohistochemical and ultrastructural studies , 1997, Virchows Archiv.

[52]  H. Asamura,et al.  Nuclear DNA content by cytofluorometry of stage I adenocarcinoma of the lung in relation to postoperative recurrence. , 1989, Chest.

[53]  S. Hirohashi,et al.  Association of point mutation in c‐Ki‐ras oncogene in lung adenocarcinoma with particular reference to cytologic subtypes , 1990, Cancer.

[54]  Lofland Hb.  Animal model of human disease. , 1975, The American journal of pathology.

[55]  K. Kerr,et al.  Atypical alveolar hyperplasia: Relationship with pulmonary adenocarcinoma, p53, and c‐erbB‐2 expression , 1994, The Journal of pathology.

[56]  Y. Nishiwaki,et al.  Monoclonality of atypical adenomatous hyperplasia of the lung. , 1999, The American journal of pathology.

[57]  H. Nagura,et al.  Immunohistochemical study of carcinoembryonic antigen in patients with colorectal cancer. Correlation with plasma carcinoembryonic antigen levels , 1985, Cancer.

[58]  A. Fraire,et al.  Alveolar cell hyperplasia in association with adenocarcinoma of lung. , 1995, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[59]  Masanobu Kitaoawa.  AUTOPSY STUDY OF LUNG CANCER WITH SPECIAL REFERENCE TO SCAR CANCER , 1965 .

[60]  K. Kerr,et al.  The association between atypical adenomatous hyperplasia and primary lung cancer , 2000, British Journal of Cancer.

[61]  A. Gazdar,et al.  K-ras mutations are a relatively late event in the pathogenesis of lung carcinomas. , 1994, Cancer research.

[62]  R W Ellis,et al.  Human genome contains four genes homologous to transforming genes of Harvey and Kirsten murine sarcoma viruses. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[63]  A. Liebow,et al.  Relationship of interstitial pneumonia honeycombing and atypical epithelial proliferation to cancer of the lung , 1965, Cancer.

[64]  H. Yokoo,et al.  Peripheral lung cancers arising in scars , 1961, Cancer.

[65]  Tohru Takahashi,et al.  Computer‐assisted pathology of intraepithelial adenocarcinoma and related lesions: 3‐D distribution, structural aberration and discrimination , 1995, Journal of cellular biochemistry. Supplement.

[66]  R. Hruban,et al.  K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. , 1996, Cancer research.

[67]  M. Kitagawa.  Autopsy study of lung cancer with special reference to scar cancer. , 1965, Acta pathologica japonica.

[68]  R. Chiba,et al.  Atypical adenomatous hyperplasia of the lung and its differentiation from adenocarcinoma. Characterization of atypical cells by morphometry and multivariate cluster analysis , 1993, Cancer.

[69]  M. Noguchi,et al.  The development and progression of adenocarcinoma of the lung. , 1995, Cancer treatment and research.

[70]  Kenji Suzuki,et al.  The prognosis of resected lung carcinoma associated with atypical adenomatous hyperplasia , 1997 .

[71]  Y. Shimosato,et al.  Morphometric study of adenocarcinomas and hyperplastic epithelial lesions in the peripheral lung. , 1986, American journal of clinical pathology.

[72]  G. Cooper,et al.  Cellular transforming genes. , 1982, Science.

[73]  H. Spencer,et al.  A Study of the Origin and Development of Lung Cancer , 1953, Thorax.

[74]  J. Minna,et al.  Non-small cell lung cancer. Part I: Biology, diagnosis, and staging. , 1991, Current problems in cancer.

[75]  D. Shibata,et al.  c-k-ras and p53 mutations occur very early in adenocarcinoma of the lung. , 1994, The American journal of pathology.

[76]  Nowell Pc.  Cancer, chromosomes, and genes. , 1992 .

[77]  D. Lowy,et al.  Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus , 1982, Nature.

[78]  P. Cagle,et al.  Natural history of pulmonary scar cancers clinical and pathologic implications , 1985, Cancer.

[79]  Takaaki Ito,et al.  Atypical adenomatous hyperplasia of the lung. Implications for the pathogenesis of peripheral lung adenocarcinoma. , 1999, American journal of clinical pathology.

[80]  中山 治彦.  Clonal growth of atypical adenomatous hyperplasia of the lung : cytofluorometric analysis of nuclear DNA content , 1993 .

[81]  Y. Kameda,et al.  Analysis of p21Waf1/Cip1 expression in normal, premalignant, and malignant cells during the development of human lung adenocarcinoma. , 1997, The American journal of pathology.

[82]  中西 邦昭.  Alveolar epithelial hyperplasia and adenocarcinoma of the lung , 1990 .

[83]  Y. Soini,et al.  Evidence by in situ hybridization that c-erbB-2 proto-oncogene expression is a marker of malignancy and is expressed in lung adenocarcinomas. , 1992, American journal of respiratory cell and molecular biology.

[84]  M. Boon,et al.  Analysis of the performance of pathologists in the grading of bladder tumors. , 1983, Human pathology.

[85]  I. Verma,et al.  Expression of cellular oncogenes in human malignancies. , 1984, Science.

[86]  M. Hollstein,et al.  Clinical implications of the p53 tumor-suppressor gene. , 1993, The New England journal of medicine.

[87]  S. Rodenhuis,et al.  Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. , 1988, Cancer research.

[88]  M. Akiyama,et al.  Immunohistochemical and Ultrastructural Studies , 1993, The American Journal of dermatopathology.

[89]  Yoshiro,et al.  Genesis of squamous cell lung carcinoma. Sequential changes of proliferation, DNA ploidy, and p53 expression. , 1994, The American journal of pathology.

[90]  H. Popper,et al.  Atypical pneumocyte hyperplasia a probable precursor lesion of bronchioloalveolar adenocarcinoma of the lung , 1994 .

[91]  D. Carter,et al.  Scar cancers of the lung: origin and significance. , 1984, Human pathology.

[92]  D. Carter.  Pathology of early squamous cell carcinoma of the lung. , 1978, Pathology annual.

[93]  R. Jagoe,et al.  Morphometric study oflivercellnuclei inhepatomas using aninteractive computertechnique: (i) nuclear size andshape , 1982 .

[94]  R. Metcalf,et al.  p53 protein accumulates frequently in early bronchial neoplasia. , 1993, Cancer research.

[95]  A quantitative study of the size of benign and malignant lymphoid follicles. , 1983, Journal of clinical pathology.

[96]  G. Boorman.  Pathology of the Fischer rat : reference and atlas , 1990 .

[97]  Scar carcinomas of the lung in a histoplasmosis endemic area , 1990, Cancer.

[98]  H. Spencer.  Pathology of the lung. Vol. 1. , 1985 .

[99]  P. Ganly,et al.  p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus. , 1992, Oncogene.

[100]  淺村 尚生.  DNA cytofluorometric and nuclear morphometric analyses of lung adenocarcinoma , 1993 .

[101]  Y. Inayama,et al.  Atypical adenomatous hyperplasia and bronchoalveolar lung carcinoma. Analysis by morphometry and the expressions of p53 and carcinoembryonic antigen. , 1996, The American journal of surgical pathology.

[102]  K. Nakanishi,et al.  Argyrophilic nucleolar-organizer region counts and DNA status in bronchioloalveolar epithelial hyperplasia and adenocarcinoma of the lung. , 1998, Human pathology.

[103]  Y. Nishiwaki,et al.  Synchronous double primary lung carcinomas associated with multiple atypical adenomatous hyperplasia. , 1998, Lung cancer.

[104]  R. Edwards,et al.  A flexible microprocessor system for the measurement of cell size. , 1982, Journal of clinical pathology.

[105]  H. Nagura,et al.  Varying grades of epithelial atypia in the pancreatic ducts of humans. Classification based on morphometry and multivariate analysis and correlated with positive reactions of carcinoembryonic antigen. , 1994, Archives of pathology & laboratory medicine.

[106]  Tohru Takahashi,et al.  Atypical adenomatous hyperplasia and adenocarcinoma of the human lung: Their heterology in form and analogy in immunohistochemical characteristics , 1996, Cancer.

[107]  R. Weinberg,et al.  Isolation of a transforming sequence from a human bladder carcinoma cell line , 1982, Cell.

[108]  M. Lairmore,et al.  Lesions and Retroviruses Associated with Naturally Occurring Ovine Pulmonary Carcinoma (Sheep Pulmonary Adenomatosis) , 1988, Veterinary pathology.

[109]  H. Reznik-Schüller,et al.  Morphology of spontaneous and induced tumors in the bronchiolo-alveolar region of F344 rats. , 1982, Anticancer research.

[110]  M. Melamed,et al.  Morphogenesis of lung cancer , 1982 .

[111]  I. Wistuba,et al.  Precursors to Pulmonary Neoplasia , 1998, Advances in anatomic pathology.

[112]  Y. Soini,et al.  Concurrent p53 expression in bronchial dysplasias and squamous cell lung carcinomas. , 1993, The American journal of pathology.